Key points are not available for this paper at this time.
Cytotoxic T cells in the blood of patients with PDAC remain sensitive to reinvigoration by PD-1 blockade, and some have tumor-recognizing potential. Although these T cells proliferate and have a signature of IFN exposure, they also upregulate NF-κB signaling, which potentially counteracts the beneficial effects of anti-PD-1 reinvigoration and marks these T cells as non-productive contributors to antitumor immunity. See related commentary by Lander and DeNardo, p. 474.
Building similarity graph...
Analyzing shared references across papers
Loading...
Lestat R. Ali
Patrick J. Lenehan
Victoire Cardot‐Ruffino
Clinical Cancer Research
Harvard University
Brigham and Women's Hospital
Massachusetts General Hospital
Building similarity graph...
Analyzing shared references across papers
Loading...
Ali et al. (Thu,) studied this question.
www.synapsesocial.com/papers/69d6c45139aaaf0da5ab359f — DOI: https://doi.org/10.1158/1078-0432.ccr-23-1444